← Back to Search

Corticosteroid

Anastrazole and Testosterone for Insulin Resistance

N/A
Waitlist Available
Led By Karen L Herbst, PhD, MD
Research Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group

Summary

This trial is testing different treatments involving testosterone to see if they can help build muscle, reduce fat, and improve how the body handles sugar. Researchers believe that testosterone will improve body composition and insulin sensitivity, with different effects depending on the additional treatments used. Testosterone therapy has been shown to increase muscle mass, reduce fat, and improve insulin sensitivity in various studies.

Eligible Conditions
  • Insulin Resistance
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: TestosteroneExperimental Treatment3 Interventions
Group II: Dutasteride and TestosteroneExperimental Treatment3 Interventions
Group III: Anastrazole and TestosteroneExperimental Treatment4 Interventions
Group IV: PlaceboActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Anastrazole
2009
Completed Phase 4
~270
Testosterone
FDA approved
Dutasteride
FDA approved
Gonadorelin
FDA approved

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead Sponsor
2,444 Previous Clinical Trials
4,331,141 Total Patients Enrolled
93 Trials studying Insulin Resistance
13,415 Patients Enrolled for Insulin Resistance
University of California, San DiegoOTHER
1,180 Previous Clinical Trials
1,574,999 Total Patients Enrolled
3 Trials studying Insulin Resistance
122 Patients Enrolled for Insulin Resistance
Karen L Herbst, PhD, MDPrincipal InvestigatorUniversity of California, San Diego
2 Previous Clinical Trials
539 Total Patients Enrolled
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top